{"id":"https://openalex.org/W2255307237","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.19035","title":"A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15\u2013070) in combination with docetaxel in patients with relapsed non-small cell lung cancer (NSCLC)","display_name":"A phase I trial of the small molecule pan-bcl-2 inhibitor obatoclax (GX15\u2013070) in combination with docetaxel in patients with relapsed non-small cell lung cancer (NSCLC)","publication_year":2008,"publication_date":"2008-05-20","ids":{"openalex":"https://openalex.org/W2255307237","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.19035","mag":"2255307237"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2008.26.15_suppl.19035","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.19035","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.19035","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064494204","display_name":"Eric B. Haura","orcid":"https://orcid.org/0000-0003-3114-1909","observed_orcids":["https://orcid.org/0000-0003-3114-1909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. B. Haura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110387325","display_name":"C. A. Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. A. Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080538468","display_name":"Alberto Chiappori","orcid":"https://orcid.org/0000-0003-0810-7104","observed_orcids":["https://orcid.org/0000-0003-0810-7104"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. A. Chiappori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. Adams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Adams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082934211","display_name":"DW Northfelt","orcid":"https://orcid.org/0000-0002-5850-0118","observed_orcids":["https://orcid.org/0000-0002-5850-0118"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. W. Northfelt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084821298","display_name":"Simran Malik","orcid":"https://orcid.org/0000-0003-0839-1299","observed_orcids":["https://orcid.org/0000-0003-0839-1299"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. M. Malik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022167761","display_name":"David Van Echo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Van Echo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063441489","display_name":"Martin Joseph Edelman","orcid":"https://orcid.org/0000-0002-3752-0726","observed_orcids":["https://orcid.org/0000-0002-3752-0726"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. J. Edelman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"M. Berger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Berger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"15_suppl","first_page":"19035","last_page":"19035"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.8398000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.8398000001907349,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.08609999716281891,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.03240000084042549,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obatoclax","display_name":"obatoclax","score":0.9940000176429749},{"id":"https://openalex.org/keywords/gx15-070","display_name":"GX15-070","score":0.949999988079071},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.9129999876022339},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6579999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8759999871253967},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6489999890327454},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.5249999761581421},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3840000033378601},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.6690000295639038},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8823043704032898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8205808401107788},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.586830198764801},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5637645125389099},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5634297728538513},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.5231995582580566},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.47451964020729065},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.4438725411891937},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4406006634235382},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4266376793384552},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.41299664974212646},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3680216670036316},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3530704379081726},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34999167919158936},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2008.26.15_suppl.19035","doi":"https://doi.org/10.1200/jco.2008.26.15_suppl.19035","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2008.26.15_suppl.19035","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2074502555","https://openalex.org/W2246927775","https://openalex.org/W2029712223","https://openalex.org/W2245349746","https://openalex.org/W2243956249","https://openalex.org/W143551698","https://openalex.org/W2153423658","https://openalex.org/W2375814880","https://openalex.org/W92771250","https://openalex.org/W1993262549"],"abstract_inverted_index":{"19035":[0],"Background:":[1],"Over":[2],"expression":[3],"of":[4,23,188,236,266,292,306],"bcl-2":[5],"family":[6],"proteins":[7],"is":[8,53,391],"common":[9],"in":[10,20,44,201,218,224,259,262,272,278,280,284,368,384,395,400],"NSCLC":[11,24],"and":[12,88,115,131,143,155,167,182,199,220,256,276,282,299,313,336,339,350,359],"the":[13,54,186,189,304,325,372],"BH-3":[14],"mimetic":[15],"obatoclax":[16],"(O)":[17],"induces":[18],"apoptosis":[19],"a":[21,60,94,107,396],"subset":[22],"where":[25],"it":[26],"synergizes":[27],"with":[28,59,379,381],"cisplatin":[29],"(Li":[30],"et":[31],"al.,":[32],"Cancer":[33],"Chemother.":[34],"Pharmacol.,":[35],"2008).":[36],"Single":[37],"agent":[38],"O":[39,58,104,132,144,156,168,190,267,293,374],"has":[40],"shown":[41],"clinical":[42],"activity":[43],"hematological":[45],"indications":[46],"across":[47],"3":[48,118],"Phase":[49],"I":[50],"trials.":[51],"This":[52],"first":[55],"trial":[56,399],"combining":[57],"cytotoxic,":[61],"docetaxel":[62],"(D).":[63],"Methods:":[64],"Eligibility":[65],"criteria":[66],"included":[67],"advanced":[68],"stage":[69],"IIIB/IV":[70],"NSCLC,":[71],"prior":[72,227],"paclitaxel":[73],"(but":[74],"not":[75],"D)":[76],"allowed,":[77],"measurable":[78],"disease,":[79],"ECOG":[80],"PS":[81,215,221],"\u22641,":[82],"disease":[83],"progression,":[84],"adequate":[85],"hematological,":[86],"renal":[87],"hepatic":[89],"function.":[90],"D":[91,128,140,152,164,380],"given":[92,105],"as":[93,106],"1":[95,114,223,230],"h":[96,109,184],"infusion":[97,111,307],"on":[98,112],"day1":[99],"followed":[100],"by":[101,389],"flat":[102],"dose":[103,319],"24":[108],"continuous":[110],"days":[113],"2,":[116],"every":[117],"weeks":[119],"for":[120],"up":[121],"to":[122],"8":[123],"cycles.":[124],"Dose":[125,137,149,161,203],"Level":[126,138,150,162],"1:":[127],"55":[129],"mg/m2":[130,142,154,166],"30":[133,145,317],"mg":[134,146,158,170,318,323,342],"X":[135,147,159,171],"2;":[136,148,160],"2:":[139],"75":[141,153,165],"3:":[151],"45":[157,322],"4:":[163],"60":[169,341],"2.":[172],"PK":[173],"samples":[174],"were":[175,239,253,268,308,331,345],"obtained":[176],"at":[177,274,294,316,328,340],"1,":[178,295],"3,":[179,197,296],"24,":[180,297],"47":[181],"49":[183,300],"after":[185],"start":[187,305],"infusion.":[191],"Results:":[192],"18":[193],"patients":[194],"enrolled":[195],"(3,":[196],"6":[198,200],"consecutive":[202],"Levels).":[204],"Patient":[205],"characteristics:":[206],"11":[207,219],"male,":[208],"median":[209,226],"age":[210],"=":[211,216,222,229,232,244],"62":[212],"(range=":[213],"44\u201381),":[214],"0":[217],"7,":[225],"regimens":[228],"(range":[231],"1\u20136).":[233],"A":[234],"total":[235],"74":[237],"cycles":[238],"administered":[240,378],"(median":[241],"4,":[242],"range":[243],"1\u20138).":[245],"The":[246,286,386],"only":[247,271],"Grade":[248],"3\u20134":[249],"adverse":[250],"events":[251],"(AEs)":[252],"dyspnea":[254],"(11%)":[255,358],"neutropenia":[257],"(none":[258],"DL1,":[260],"60%":[261],"DL2\u20134).":[263],"Known":[264],"AEs":[265],"infrequent:":[269],"somnolence":[270],"1/6":[273,283],"DL4":[275,390],"euphoria":[277],"1/3":[279],"DL2":[281],"DL3.":[285],"mean":[287],"\u00b1":[288],"SD":[289,362],"plasma":[290],"concentration":[291],"47,":[298],"hr":[301],"time-points":[302,330],"from":[303],"2.61\u00b11.96,":[309],"2.00\u00b11.43,":[310],"3.94\u00b12.88,":[311],"4.04\u00b13.33,":[312],"1.61\u00b10.86,":[314],"respectively":[315],"level.":[320],"At":[321],"dose,":[324],"mean\u00b1SD":[326],"concentrations":[327,344],"same":[329],"5.00\u00b11.59,":[332],"6.21\u00b12.24,":[333],"4.26\u00b12.01,":[334],"7.32\u00b12.84,":[335],"2.42\u00b11.30,":[337],"respectively,":[338],"those":[343],"5.03\u00b14.61,":[346],"8.16\u00b13.17,":[347],"10.34\u00b17.34,":[348],"12.44\u00b19.42,":[349],"5.45\u00b12.25,":[351],"respectively.":[352],"There":[353],"have":[354],"been":[355],"2":[356],"PRs":[357],"4":[360],"confirmed":[361],"(22%).":[363],"Early":[364],"PD":[365],"was":[366],"noted":[367],"9":[369],"(50%).":[370],"Conclusions:":[371],"BH3-mimetic":[373],"can":[375],"be":[376],"safely":[377],"no":[382],"increase":[383],"neutropenia.":[385],"regimen":[387],"described":[388],"currently":[392],"being":[393],"evaluated":[394],"phase":[397],"II":[398],"relapsed":[401],"NSCLC.":[402],"Author":[403],"Disclosure":[404],"Employment":[405],"or":[406,409],"Leadership":[407],"Consultant":[408],"Advisory":[410],"Role":[411],"Stock":[412],"Ownership":[413],"Honoraria":[414],"Research":[415],"Expert":[416],"Testimony":[417],"Other":[418],"Remuneration":[419],"GeminX":[420,421]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}